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A B S T R A C T
A versatile pathway for the synthesis of 7-cycloalkylimino substituted 3-amino-6-ﬂuoro-2-methyl-3H-
quinazolin-4-ones from 4,5-diﬂuoroanthranylic acid has been advanced. Nucleophilic amination–
deﬂuorination reaction of the 6,7-diﬂuoro derivative of 3-amino-2-methyl-3H-quinazolin-4-one has
been established to occur at position 7, as shown by X-ray crystallographic analysis.
 2012 Elsevier B.V. All rights reserved.
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3-Amino-7-cycloalkylimino substituted 6-ﬂuoroquinazolin-
2,4-diones have recently been identiﬁed as high effective
inhibitors of the bacterial type-2 topoisomerase [1]. Nucleophilic
displacement of ﬂuorine atoms proved to be a versatile synthetic
tool for structural modiﬁcations of ﬂuorinated quinazolin-4-ones
[2], however the available data on the synthesis of biologically
active compounds through amination–deﬂuorination of diﬂuor-
oquinazolines are limited with a few publications [3], dealing
mainly with substitution of a ﬂuorine atom in the benzene ring [4].
Meanwhile, quinazolines, bearing a ﬂuorine atom and a cycloalk-
ylimino moiety in the benzene ring, are of interest due to a
profound antitumor activity exhibited by 2-aryl-7-ﬂuoro-6-(4-
methylpiperazin-1-yl)-4(3H)-quinazolin-4-one, obtained in 5
steps from 4-ﬂuoro-2-nitro-5-(4-methylpiperazin-1-yl)aniline
[5]. It should be noted that hydrazination-deﬂuorination at C(7)-
F in 3-amino-6,7,8-triﬂuoro-2-methylquinazolin-4-one was de-
scribed earlier [6], although no data on substitution of F(7) in 6,7-
diﬂuoro-2-methylquinazolin-4-one are available in the literature.
Here we report a simple synthetic approach toward new
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Heating of diﬂuorobenzoxazinone 1 with hydrazine hydrate for
a short time did not result in displacement of ﬂuorine atom at 7-
position with the hydrazino moiety, as shown earlier [6]. The
optimal conditions for preparation of diﬂuoroquinazolonone 2
proved to be reﬂux of 1 with 1.5 equiv. of hydrazine hydrate in
ethanol for 1 h. Also the compound 3 was obtained in a high yield
when benzoxazinone 1 was allowed to be kept on reﬂux in ethanol
with 4 equiv. of hydrazine hydrate for 10 h in order to transform
the oxazine ring into the pyrimidine one, as well as to cause
substitution of ﬂuorine atom at 7-position with hydrazine. The
structure of hydrazine compound 3 is evidenced by 1H NMR
spectra, showing the presence of NHNH2 group signals in addition
to doublets of H(5) and H(8) protons (scheme).
The ﬂuorine atom at position 7 of 3-amino-6,7-diﬂuoro-2-
methyl-3H-quinazolin-4-one (2) was shown to be displaced
smoothly by action cycloalkylimines to give compounds 4 in high
yields on heating under reﬂux with 1-methylpiperazine, 3-
methylpiperidine, morpholine or 1-ethoxycarbonylpiperazine in
DMSO for 9 h (Scheme 1).
The structure of ﬂuoroquinazolines 4a–d was substantiated
with 1H NMR, 19F NMR and mass spectrometry data. The 1H NMR
spectra of 4a–d reveal two doublets of H(5) and H(8) protons with
the characteristic values of coupling constants 3J[H(5), F(6)] and
4J[H(8), F(6)] in the ranges of 12.8–13.1 and 7.9–8.1 Hz corre-
spondingly.
Since displacement of F(6) atom would also give a rise to two
doublets in 1H NMR with close values of 3J[H(8), F(7)] and
FF N
N
O
NH
2
Me
HNRR'
F
N N
N
O
NH
2
Me
R
R'
F
F N
O
O
Me
F
NH N
N
O
NH
2
Me
NH
2
H2N-NH2.H2O
H2N-NH2.H2O
DMSO, 120    C,  9 h
80   C,  1 h
4 eq, 80    C, 10  h
1 2
4a-d
3
1.5 eq
0
0
0
Scheme 1. Compounds 4: NRR0 = 4-methylpiperazin-1-yl (a), 3-methylpiperidin-1-
yl (b), morpholin-4-yl (c), 4-ethoxycarbonylpiperazin-1-yl (d).
Fig. 1. Molecular structure for quinazolinone 4b.
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for the proof of products 4a–d structure. Convincing arguments
for displacement of F(7), but not F(6), have been obtained by the
X-ray crystallography analysis performed for compound 4b
(Fig. 1).
According to the X-ray data compound 4b is crystallized in
centrosymmetric space group of monoclinic system. General
geometry of the compound (bond length and angles) does not
exhibit any signiﬁcant deviations from standard values. Molec-
ular packing is formed by layers of molecules oriented on axe 0b.
Interactions in layers is realized by H-bonds between NH2-
group and nitrogen of pyrimidine: with d(N2  N1[x + 3/2,
y + 1/2, z + 1/2]) = 3.061 A˚. Hydrogen atoms at N(2) were added
in calculated positions and reﬁned in the riding model.
The multiplete character of signals of F(6) in the 19F NMR
spectra of quinazolinones 3 and 4a–d indicates that F(6) is
coupled with not only H(5) and H(8) protons of the benzene
ring, but also with CH2-protones of the cycloalkylimino group in
case of compounds 4, or with NH-proton of the hydrazine group
in case of compound 3. It is worth noting that spin–spin
couplings of F(6) with protons of the cycloalkylimino fragments
at position 7 of [i,j]-annelated ﬂuoroquinolones have also been
described in the paper [7].
3. Conclusion
A versatile synthetic route to the family of 7-substituted 6-
ﬂuoroquinazolinones 4 has been developed. Presently, the
antibacterial and antifungal properties of these compounds are
under investigation. The corresponding results will be reported
elsewhere in due course.4. Experimental
4.1. General
X-ray structural analyses of compound 4b was accomplished
with using ‘‘Xcalibur S’’ diffractometer with CCD (l(Mo
Ka) = 0.71073 A˚, T = 295(2) K, v-scans with 1.08 steps in v and
20 s per frame exposure) for prismatic light brown crystal
0.25 mm  0.20 mm  0.15 mm. Absorption correction not per-
formed (m = 0.092 mm1). Crystal is monoclinic, a = 11.1363(16) A˚,
b = 12.3042(10) A˚, c = 11.7801(17) A˚, b = 111.457(13), space group
P21/n. In limits 3.168 < u < 28.298 7879 reﬂections were collected,
3478 independent reﬂections (Rint = 0.0409), 1042 reﬂections with
I > 2s(I). Completeness for u = 26.008 95.7%. The structure was
solved by direct method and reﬁned by full-matrix least-squares
technique against on F2 in anisotropic (isotropic for H-atoms)
approximation. Hydrogen atoms were located from Fourier
synthesis and reﬁned in riding model. All calculations were
performed using SHELXTL [8]. Results of reﬁnement: R1 = 0.0630,
wR2 = 0.1585 (for I > 2s(I)), R1 = 0.1720, wR2 = 0.1714 (for all data),
S = 1.005. Dre¯ ¼ 0:552=  0:200 e¯A˚
3
.
The X-ray diffraction data for structure 4b have been deposited
with the Cambridge Crystallographic Data Center (CCDC No.
885182). These data are free and can be made available upon
request at www.ccdc.cam.ac.uk/data_request/cif.
Synthesis of compound 2 from 4,5-diﬂuoroanthranylic acid was
reported in [6], the reaction time for transformation 1–2 was
diminished to 1 h.
NMR, MS and analytical data for compound obtained are
presented in Supporting Information.
4.2. Synthesis of 3-amino-6-ﬂuoro-7-hydrazino-2-methyl-3H-
quinazolin-4-one (3)
Hydrazine hydrate (98%) (0.4 mL, 8 mmol) was added to a
solution of benzoxazinone 1 (0.4 g, 2 mmol) in 10 mL of ethanol.
The reaction mixture was kept at 80 8C reﬂux for 10 h. After the
mixture was cooled, the precipitate formed was collected by
ﬁltration and washed with water (15 mL) to give 0.45 g (92%) of 3,
mp 238–240 8C.
4.3. Typical procedure for the synthesis of 3-amino-7-
cycloalkylimino-6-ﬂuoro-2-methyl-3H-quinazolin-4-ones 4a-d
The 1-methylpiperazine 1a (0.4 g, 4 mmol) was added to a
solution of diﬂuoroquinazolinone (2) (0.3 g, 1.5 mmol) in 2 mL of
DMSO. The reaction mixture was heated at 120 8C for 9 h. After the
mixture was cooled the precipitate formed was collected by
ﬁltration, washed with hot ethanol (5 mL) and recrystallized from
DMSO to give 0.36 g (82%) of 4a.
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